TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer

TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer

TP53 mutation is a critical driver mutation that affects the carcinogenesis and prognosis of patients with pancreatic cancer (PC). Currently, there is no driver mutation-derived signature based on TP53 mutational status for prognosis and predicting therapeutic response in PC. In the present study, w...

Full description

Bibliographic Details
Main Authors:	Feng Zhang, Wenhui Zhong, Honghao Li, Kaijun Huang, Min Yu, Yubin Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	TP53 mutation pancreatic cancer signature prognosis therapeutic responses
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.665265/full

Similar Items

The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma
by: Hongpan Zhang, et al.
Published: (2021-06-01)

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
by: Venkatesh Kancherla, et al.
Published: (2018-02-01)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
by: Chunguang Guo, et al.
Published: (2022-03-01)

Gaining insights into relevance across cancers based on mutation features of TP53 gene
by: Yue Mei, et al.
Published: (2021-12-01)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
by: Xuerui Li, et al.
Published: (2020-07-01)

Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis
by: Wei Wu, et al.
Published: (2018-08-01)

A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer
by: Xun Liu, et al.
Published: (2021-03-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01)

A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
by: Feng Xu, et al.
Published: (2020-01-01)

TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
by: Ziwen Zhang, et al.
Published: (2021-11-01)

STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
by: Shanshan Hu, et al.
Published: (2020-09-01)

TP53 Mutations in Esophageal Squamous Cell Carcinoma
by: Leqi Zhong, et al.
Published: (2023-09-01)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
by: Hua-Ping Liu, et al.
Published: (2023-03-01)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022-01-01)

Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer
by: Wensheng Jiang, et al.
Published: (2023-03-01)

TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
by: Yiran Zhou, et al.
Published: (2023-12-01)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01)

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
by: Congyu Shi, et al.
Published: (2021-09-01)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
by: Dmitriy Sonkin
Published: (2015-10-01)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
by: Junyu Huo, et al.
Published: (2021-06-01)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients
by: Jian Zhang, et al.
Published: (2022-03-01)

A novel strategy for precise prognosis management and treatment option in colon adenocarcinoma with TP53 mutations
by: Lei Niu, et al.
Published: (2023-02-01)

TP53 mutations in Romanian patients with colorectal cancer
by: Felix Manirakiza, et al.
Published: (2023-07-01)

Analysis of mutation and promoter methylation of TP53 gene in tumors of the head and neck
by: Jarzynski Adrian, et al.
Published: (2016-06-01)

Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation
by: Dejun Zeng, et al.
Published: (2021-10-01)

Mutation analysis of TP53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan.
by: Mian Adnan Kakakhel, et al.
Published: (2021-02-01)

Quantitative Analysis of TP53-Related Lung Cancer Based on Radiomics
by: Qiao H, et al.
Published: (2022-12-01)

The spectrum of TP53 mutations in Rwandan patients with gastric cancer
by: Augustin Nzitakera, et al.
Published: (2024-03-01)

Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017)
by: Christian S. Alvarez, et al.
Published: (2020-06-01)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
by: Čolović Nataša, et al.
Published: (2023-01-01)

Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
by: N Pouladi, et al.
Published: (2016-02-01)

Mesonephric Adenocarcinoma of the Vagina Harboring <i>TP53</i> Mutation
by: Hyunjee Lee, et al.
Published: (2022-01-01)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
by: Go Omura, et al.
Published: (2017-12-01)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
by: Xiang-mei Wen, et al.
Published: (2021-10-01)

The <it>R337H </it>mutation in <it>TP53 </it>and breast cancer in Brazil
by: Gomes Magda CB, et al.
Published: (2012-03-01)

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
by: Fernando Barroso Duarte, et al.
Published: (2017-05-01)

Frequency of hyperglycemia and polymorphism of TNF and TP53 genes in patients with acute pancreatitis, chronic pancreatitis, pancreatic cancer
by: I. N. Grigor’eva, et al.
Published: (2022-02-01)

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
by: Lijuan Zhang, et al.
Published: (2023-12-01)